4//SEC Filing
Anika Therapeutics, Inc. 4
Accession 0001171843-17-003274
$ANIKCIK 0000898437operating
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:56 PM ET
Size
6.8 KB
Accession
0001171843-17-003274
Insider Transaction Report
Form 4
Thompson Jeffery S
Director
Transactions
- Sale
Common Stock
2017-05-19$47.58/sh−1,097$52,195→ 15,845 total - Sale
Common Stock
2017-05-22$47.37/sh−9,628$456,078→ 6,217 total
Footnotes (2)
- [F1]Represents the weighted average sales price. The shares were sold on 5/19/2017 at prices ranging from $47.56 to $47.61 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request.
- [F2]Represents the weighted average sales price. The shares were sold on 5/22/2017 at prices ranging from $47.25 to $47.45 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000898437
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:56 PM ET
- Size
- 6.8 KB